FDA panel backs Merck’s at-home COVID pill
A United States Food and Drug Administration (FDA) advisory committee determined that benefits outweigh the risks and endorsed Merck and Ridgeback Biotherapeutics’ COVID-19 treatment pill.
If off…
A United States Food and Drug Administration (FDA) advisory committee determined that benefits outweigh the risks and endorsed Merck and Ridgeback Biotherapeutics’ COVID-19 treatment pill.
If off…